Electrical probing of COVID-19 spike protein receptor binding domain via a graphene field-effect transistor

Xiaoyan Zhang, Qige Qi, Qiushi Jing, Shen Ao, Zhihong Zhang, Mingchao Ding, Muhong Wu, Kaihui Liu, Weipeng Wang, Yunhan Ling, Zhengjun Zhang, Wangyang FuarXiv 2020 · DOI · arXiv

Abstract

Here, in an effort towards facile and fast screening/diagnosis of novel coronavirus disease 2019 (COVID-19), we combined the unprecedently sensitive graphene field-effect transistor (Gr-FET) with highly selective antibody-antigen interaction to develop a coronavirus immunosensor. The Gr-FET immunosensors can rapidly identify (about 2 mins) and accurately capture the COVID-19 spike protein S1 (which contains a receptor binding domain, RBD) at a limit of detection down to 0.2 pM, in a real-time and label-free manner. Further results ensure that the Gr-FET immunosensors can be promisingly applied to screen for high-affinity antibodies (with binding constant up to 2*10^11 M^-1 against the RBD) at concentrations down to 0.1 pM. Thus, our developed electrical Gr-FET immunosensors provide an appealing alternative to address the early screening/diagnosis as well as the analysis and rational design of neutralizing-antibody locking methods of this ongoing public health crisis.

Introduction

The COVID-19 pandemic highlighted a desperate need for diagnostic tools that are simultaneously fast, highly sensitive, and easy to use. While RT-PCR is the gold standard for accuracy, it requires bulky equipment and hours of processing time. Protein-based tests like ELISA often require complex labeling procedures and optical readers. This research describes the development of a "digital" immunosensor based on a graphene field-effect transistor (Gr-FET) that provides a direct electrical readout of viral proteins with enough sensitivity to catch infections at their earliest stages.

Methods and Device Architecture

The researchers utilized a Gr-FET as the sensing platform. Graphene is an ideal material for biosensing because every atom is on the surface, making its electrical conductivity extremely sensitive to nearby charged molecules.

Schematic of the Gr-FET immunosensor (a) and the characteristic conductance shift (b) following antibody functionalization.

The device was fabricated using high-quality monolayer graphene grown via Chemical Vapor Deposition (CVD). The surface was functionalized with either the SARS-CoV-2 spike S1 subunit antibody (CSAb) or the human ACE2 receptor. To overcome "ionic screening"—where ions in a buffer solution shield the sensor from the target protein's electric field—the authors used a diluted PBS buffer. This extended the Debye length to ~7 nm, matching the size of the antibodies and allowing the sensor to detect binding events effectively.

Key Insights and Results

The Gr-FET immunosensor demonstrated exceptional performance in detecting the COVID-19 spike protein S1:

  • High Sensitivity: The Limit of Detection (LOD) for the S1 protein reached 0.2 pM, rivaling laboratory-based ELISA tests without the need for labels.
  • Rapid Response: Real-time detection occurred within just 2 minutes.
  • Superior Binding Affinity: The CSAb-modified sensor was significantly more sensitive than the ACE2-modified version, with a binding affinity ($K$) of $2 \times 10^{11} \text{ M}^{-1}$.
  • Dual Utility: Beyond virus detection, the sensor can be used to rapidly screen for high-affinity neutralizing antibodies at concentrations as low as 0.1 pM, a critical capability for vaccine development.

To ensure reliability across different sensor samples, the team normalized the change in conductance ($\Delta G$) by the transconductance ($g_m$), yielding a consistent voltage shift ($\Delta V_{ref}$).

Limitations and Future Directions

While the results are promising, several challenges remain for widespread adoption. Future work must validate the sensor's performance in complex biological fluids like saliva or blood, where non-specific binding (biofouling) is more prevalent. Additionally, scaling the precise functionalization steps for mass industrial production will be necessary to meet global diagnostic demands.

Summary updated

Abstract

Here, in an effort towards facile and fast screening/diagnosis of novel coronavirus disease 2019 (COVID-19), we combined the unprecedently sensitive graphene field-effect transistor (Gr-FET) with highly selective antibody-antigen interaction to develop a coronavirus immunosensor. The Gr-FET immunosensors can rapidly identify (about 2 mins) and accurately capture the COVID-19 spike protein S1 (which contains a receptor binding domain, RBD) at a limit of detection down to 0.2 pM, in a real-time and label-free manner. Further results ensure that the Gr-FET immunosensors can be promisingly applied to screen for high-affinity antibodies (with binding constant up to 2*10^11 M^-1 against the RBD) at concentrations down to 0.1 pM. Thus, our developed electrical Gr-FET immunosensors provide an appealing alternative to address the early screening/diagnosis as well as the analysis and rational design of neutralizing-antibody locking methods of this ongoing public health crisis.
BibTeX
@misc{zhang2020electrical,
  author = {Xiaoyan Zhang and Qige Qi and Qiushi Jing and Shen Ao and Zhihong Zhang and Mingchao Ding and Muhong Wu and Kaihui Liu and Weipeng Wang and Yunhan Ling and Zhengjun Zhang and Wangyang Fu},
  title = {{Electrical probing of COVID-19 spike protein receptor binding domain via a graphene field-effect transistor}},
  year = {2020},
  eprint = {2003.12529},
  archivePrefix = {arXiv},
  url = {https://arxiv.org/abs/2003.12529},
}

Loading related content...

Figure